Abstract:Magnolia officinalis as a traditional Chinese herb has long been used for the treatment of anxiety, cough, headache and allergic diseases, and also have been used in traditional Chinese medicine to treat a variety of mental disorders including depression.Magnolol, a hydroxylated biphenyl compound isolated from Magnolia officinalis, has been reported to have anti-inflammatory properties. However, the underlying molecular mechanisms are not well understood. The aim of this study was to investigate the molecular mechanism of magnolol in modifying lipopolysaccharide (LPS)-induced signal pathways in RAW264.7 cells.The purity of magnolol was determined by high performance liquid chromatography. RAW264.7 cells were stimulated with LPS in the presence or absence of magnolol. The expression of proinflammatory cytokines were determined by ELISA and reverse transcription-PCR. Nuclear factor-κB (NF-κB), inhibitory kappa B (IκBα) protein, p38, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and Toll-like receptor 4 (TLR4) were determined by Western blot. Further analyses were performed on mTLR4 and mMD2 co-transfected HEK293 cells.The result showed that the purity of magnolol used in this study was 100%. Magnolol inhibited the expression of TNF-α, IL-6 and IL-1β in LPS-stimulated RAW264.7 cells in a dose-dependent manner. Western blot analysis showed that magnolol suppressed LPS-induced NF-κB activation, IκBα degradation, phosphorylation of ERK, JNK and P38. Magnolol could significantly down-regulated the expression of TLR4 stimulating by LPS. Furthermore, magnolol suppressed LPS-induced IL-8 production in HEK293-mTLR4/MD-2 cells.Our results suggest that magnolol exerts an anti-inflammatory property by down-regulated the expression of TLR4 up-regulated by LPS, thereby attenuating TLR4 mediated the activation of NF-κB and MAPK signaling and the release of pro-inflammatory cytokines. These findings suggest that magnolol may be a therapeutic agent against inflammatory diseases.

Magnolol: Chemistry and Biology

Insights on the Multifunctional Activities of Magnolol

Molecular Mechanism of Pharmacological Activity of Magnolol and Honokiol Analogs

Advances on Semisynthesis, Total Synthesis, and Structure-Activity Relationships of Honokiol and Magnolol Derivatives

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

Identification and Validation of Magnolol Biosynthesis Genes in Magnolia officinalis

Mechanosynthesis of Magnolol Multicomponent Crystalline Solids for Improved Natural Antibiotics and Customizable Release Profiles.

Molecular Determinants of Magnolol Targeting Both RXRα and PPARγ

Honokiol and magnolol: A review of structure-activity relationships of their derivatives

The Neuropharmacological Effects of Magnolol and Honokiol: A Review of Signal Pathways and Molecular Mechanisms

Design, Synthesis, and Structure-Activity Relationship Studies of Magnolol Derivatives As Antifungal Agents

Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives

Development of a UHPLC-MS/MS-based data-mining method for rapid profiling and characterization of magnolol metabolites in rat urine and plasma

Cardiovascular Modulating Effects of Magnolol and Honokiol, two polyphenolic compounds from Traditional Chinese Medicine-Magnolia officinalis.

2-O-Methylmagnolol, a Magnolol Derivative, Suppresses Hepatocellular Carcinoma Progression via Inhibiting Class I Histone Deacetylase Expression

Efficient and Selective Extraction of Magnolol from Magnolia Officinalis by Mechanochemical Extraction Technique

Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.

Transcriptional And Functional Analysis Of The Effects Of Magnolol: Inhibition Of Autolysis And Biofilms In Staphylococcus Aureus

Magnolol, A Major Bioactive Constituent of the Bark of Magnolia Officinalis, Exerts Antiepileptic Effects Via the Gaba/Benzodiazepine Receptor Complex in Mice

Discovery and Synthesis of Novel Magnolol Derivatives with Potent Anticancer Activity in Non-Small Cell Lung Cancer.

Separation of Magnolol from Magnolia Officinalis by Reversed-Phase Preparative High Performance Liquid Chromatography